T-Therapeutics in a $32 million series A extension with Tencent, BGF, Sofinnova, F-Prime, Digitalis Ventures, Cambridge Innovation, Sanofi.
03 November 2025
03 November 2025
Total investments received (USD): 91.57M
Round value (USD): 32M
Company: T-Therapeutics
Industry: BiotechHealth services
Related deals
Engitix raised $25m in a Series A extension from Netherton Investments
Investments
09 December 2025
Cellular Origins raises a $40 million Series A round led by Johnson & Johnson, joined by Highland Europe, BGF, NYBC Ventures, and TTP Group
Investments
04 December 2025
Relation Tx raised $26m from insiders NVentures, DCVC, and Magnetic Ventures.
Investments
02 December 2025
EpilepsyGTx raised $33m in Series A funding from XGEN Venture and the British Business Bank.
Investments
02 December 2025
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain